Pracinostat Hydrochloride

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NamePracinostat Hydrochloride
Drug Alias Namepracinostat盐酸普诺司他盐酸普雷司他SB-939
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 2 inhibitorsHistone deacetylase 1 inhibitors
TargetsHistone deacetylase 2Histone deacetylase 1
Therapy Area/IndicationsSolid tumoursMyeloproliferative DisordersMyelodysplastic Syndromes +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[19] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesS*BIO Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPaladin Labs IncThe University Of Texas MD Anderson Cancer CenterHelsinn Birex Pharmaceuticals Ltd +[6] 
Active IndicationsN/A
Inactive IndicationsSolid tumoursMyeloproliferative DisordersMyelodysplastic Syndromes +[8] 

Other Information

ATC CodeN/A
Related LinksWikipedia